Clinical Trial Update: Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on divalproex sodium (Depakote) for explosive temper in adolescents and adults. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Cannabis Use Disorder
• Disruptive Behavior Disorders

Drugs mentioned

• DEPAKOTE (DIVALPROEX SODIUM)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Attention Deficit and Disruptive Behavior Disorders, Marijuana Abuse | Phase 3 | Status: COMPLETED